首页 | 本学科首页   官方微博 | 高级检索  
     


Current understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges
Authors:Prameela?Kandra  author-information"  >  author-information__contact u-icon-before"  >  mailto:chprameela@gmail.com"   title="  chprameela@gmail.com"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Hemalatha?Padma Jyoti?Kalangi
Affiliation:1.Department of Biotechnology, GITAM Institute of Technology,GITAM University,Visakhapatnam,India;2.Department of Biochemistry,Andhra University,Visakhapatnam,India
Abstract:Recent advances have been made in cancer chemotherapy through the development of conjugates for anticancer drugs. Many drugs have problems of poor stability, water insolubility, low selectivity, high toxicity, and side effects. Most of the chitosan nanoparticles showed to be good drug carriers because of their biocompatibility, biodegradability, and it can be readily modified. The anticancer drug with chitosan nanoparticles displays efficient anticancer effects with a decrease in the adverse effects of the original drug due to the predominant distribution into the tumor site and a gradual release of free drug from the conjugate which enhances drug solubility, stability, and efficiency. In this review, we discuss wider applications of numerous modified chitosan nanoparticles against different tumors and also focusing on the administration of anticancer drugs through various routes. We propose the interaction between nanosized drug carrier and tumor tissue to understand the synergistic interplay. Finally, we elaborate merits of drug delivery system at the tumor site, with emphasizing future challenges in cancer chemotherapy.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号